4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Amyloid in dementia associated with familial FTLD: Not an innocent bystander

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Patients with frontotemporal lobar degeneration (FTLD) can show superimposed amyloid pathology, though the impact of amyloid on the clinical presentation of FTLD is not well characterized. This cross-sectional case-control study compared clinical features, FDG-PET metabolism and gray matter volume loss in 30 patients with familial FTLD in whom amyloid status was confirmed with autopsy or PiB-PET. Compared to the amyloid negative patients, the amyloid positive patients performed significantly worse on several cognitive tests and showed hypometabolism and volume loss in more temporoparietal regions. Our results suggest that in FTLD, amyloid positivity is associated with a more AD-like pattern of neurodegeneration.

          Related collections

          Author and article information

          Journal
          9511374
          22073
          Neurocase
          Neurocase
          Neurocase
          1355-4794
          1465-3656
          16 September 2015
          04 June 2015
          February 2016
          01 February 2017
          : 22
          : 1
          : 76-83
          Affiliations
          [1 ]Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA
          [2 ]Department of Radiology, University of California, San Francisco, San Francisco, CA, USA
          [3 ]School of public health, University of California Berkeley, and Lawrence Berkeley national labs, Berkeley, CA, USA
          [4 ]Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, Los Angeled, CA, USA
          Author notes
          [* ] Corresponding Author: Georges Naasan, MD, Assistant Professor of Neurology, University of California, San Francisco, Memory and Aging Center, 1500 Owens Street, Suite 320, San Francisco, CA 94158, Phone: 415-502-0551, gnaasan@ 123456memory.ucsf.edu
          Article
          PMC4662906 PMC4662906 4662906 nihpa698858
          10.1080/13554794.2015.1046458
          4662906
          26040468
          e983a94c-2f9f-4360-9c21-744cc351b014
          History
          Categories
          Article

          assessment of cognitive disorders/dementia,Frontotemporal dementia,Alzheimer’s disease,MRI,PET,Amyloid,FDG-PET

          Comments

          Comment on this article